Lv3
400 积分 2024-07-29 加入
BK Virus Nephropathy Associated With Prolonged Immune Effector Cell–Associated Hematotoxicity Following Anti-CD19 CAR-T-Cell Therapy for Diffuse Large B-Cell Lymphoma in a Nontransplant Patient: A Case Report
1个月前
已关闭
Chimeric antigen receptor T-cell therapy in aggressive lymphomas
1个月前
已关闭
Invasive fusariosis after CD19 chimeric antigen receptor T-cell therapy
1个月前
已关闭
Chimeric antigen receptor T cell therapy in childhood leukaemia
1个月前
已关闭
Therapy related acute myeloid leukemia secondary to CAR-T therapy in refractory/relapsed multiple myeloma patient showing poor prognosis
1个月前
已完结
BK Virus Nephropathy Associated With Prolonged Immune Effector Cell–Associated Hematotoxicity Following Anti-CD19 CAR-T-Cell Therapy for Diffuse Large B-Cell Lymphoma in a Nontransplant Patient: A Case Report
1个月前
已关闭
Posterior reversible encephalopathy syndrome after CD19 chimeric antigen receptor therapy for B-acute lymphoblastic leukemia: case report
1个月前
已完结
Treatment-related adverse events of chimeric antigen receptor-T therapies for cancers in clinical trials: a systematic review and meta-analysis
1个月前
已完结
CAR-T cell therapy as an approach for pediatric hematological malignancies in regenerative therapy: Current status and clinical outcomes
1个月前
已完结
Secondary Myelodysplastic Syndrome after CD19 CAR T Therapy in Patients with Refractory/Relapsed Lymphoma
1个月前
已完结
皖公网安备34019202002308
